English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Tuesday, April 30, 2024
Press Releases for Thursday, January 20, 2022
热爆NFT「MetaBunny」元兔引领潮流 限量预售仅1小时炒至超过15倍
20:11 HKT/SGT
熱爆NFT「MetaBunny」元兔引領潮流 限量預售僅1小時炒至超過15倍
20:10 HKT/SGT
Realbox launches one of world's first blockchain-based real estate tokenization platforms
20:00 HKT/SGT
三菱重工と三菱ロジスネクスト、シグマシンクスによる倉庫物流の知能化・自動化プロジェクトが始動
15:30 HKT/SGT
Slime Royale Announces to Receive Strategic Investment and Incubation Support from Appota Group
14:00 HKT/SGT
Hitachi Rail Awarded Contract to Operate and Maintain Princess Noura Bint Abdul Rahman University Autonomous System in Riyadh, Saudi Arabia
13:14 HKT/SGT
CheckDot Announces the Launch of Its Platform Which Will Save Crypto Industry
13:00 HKT/SGT
日立建機と日立、日立建機のDX加速に向け、OT・ITデータ利活用のプラットフォームを構築
13:00 HKT/SGT
Honda、ソフトウェア技術の開発強化に向け、米国Helm.ai社に出資
12:30 HKT/SGT
Honda Invests in U.S.-based Helm.ai to Strengthen its Software Technology Development
12:04 HKT/SGT
インタービュー:2022年のEmurgo、カルダノ(ADA)について知っておくべきこと
12:00 HKT/SGT
2022년 Cardano(ADA)에 대해 알아야 할 사항
11:00 HKT/SGT
Interview: What You Need to Know about Cardano (ADA) in 2022
11:00 HKT/SGT
昭和電工、液状プライマーを用いた異種材料接合技術に関する基本特許網を構築
11:00 HKT/SGT
NEC、小規模ネットワークに適したローカル5G基地局UNIVERGE RV1000シリーズ2機種を販売開始
10:00 HKT/SGT
NexBloc and Arcade Network Partner to Bring Blockchain Domains to Gaming in the Metaverse
09:28 HKT/SGT
エーザイ、「レンビマ(R)」と「キイトルーダ(R)」の併用療法について進行性子宮内膜がんを対象とした臨床第III相309試験/KEYNOTE-775試験の結果がthe New England Journal of Medicineに掲載
09:00 HKT/SGT
ShibRWD ($SRWD)、BitMartへのプライマリー上場を発表
09:00 HKT/SGT
Eisai: Results From Pivotal Phase 3 Study 309/KEYNOTE-775 Trial of LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Advanced Endometrial Carcinoma
08:56 HKT/SGT
ACN Search:
CITIC Telecom CPC Becomes New VMware Cloud Service Provider Pinnacle Tier Partner in the Broadcom Advantage Partner Program
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575